Andere Sprachen Corcept Therapeutics Incorporated

Aktien

529882

US2183521028

CORT

Realtime-Estimate Cboe BZX Andere Börsenplätze 17:01:21 11.06.2024			% 5 Tage	% 1. Jan.
32,22 ^USD	+0,91 %		-2,34 %	-1,17 %

04.06.	CORCEPT THERAPEUTICS INCORPORATED : Truist Securities bekräftigt seine Kaufempfehlung	ZM
28.05.	Sektor-Update: Aktien des Gesundheitswesens ziehen sich am Dienstagnachmittag zurück	MT

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Groundbreaking Study by MAIA Biotechnology (NYSE: MAIA) Indicates Promising New Treatment for Advanced Lung Cancer	06.06.
Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing’s Syndrome)	03.06.
Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients with Hypercortisolism	29.05.
Sector Update: Health Care Stocks Retreat Tuesday Afternoon	28.05.
Corcept Therapeutics Says Phase 3 Hypercortisolism Trial Meets Primary Endpoint; Shares Advance	28.05.
Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing’s Syndrome)	28.05.
Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing’s Syndrome)	28.05.
Corcept Announces Primary Endpoint Met in Pivotal Phase 3 Grace Trial of Relacorilant in Patients with Hypercortisolism (Cushing?S Syndrome)	28.05.
Corcept Therapeutics Insider Sold Shares Worth $1,400,000, According to a Recent SEC Filing	16.05.
Earnings Flash (CORT) CORCEPT THERAPEUTICS INCORPORATED Reports Q1 EPS $0.25, vs. Street Est of $0.22	01.05.
Corcept: Q1 Earnings Snapshot	01.05.
Corcept Therapeutics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024	01.05.
Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update	01.05.
Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update	01.05.
Corcept Completes Enrollment in Phase 4 CATALYST Trial	29.04.
Corcept Therapeutics Incorporated Completes Enrollment in Phase 4 Catalyst Trial	29.04.
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call	24.04.
Corcept Announces Positive Results from Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients with Cushing's syndrome	23.04.
Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s Syndrome	22.04.
Corcept Therapeutics Incorporated Announces Positive Results from Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients with Cushing?s Syndrome	22.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Corcept Therapeutics Incorporated

Aktien

529882

US2183521028

CORT

Andere Sprachen

Filter